UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.14 +0.14 (+0.18%) GOLD FUTURES
2,315.10 +4.10 (+0.18%) DOW
38,258.21 +354.92 (+0.94%) Bitcoin GBP
47,167.00 +458.52 (+0.98%)
AnaptysBio, Inc. (0HFQ.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:13PM BST
| Previous close | 25.07 |
| Open | 25.89 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 24.89 - 26.12 |
| 52-week range | 13.80 - 27.27 |
| Volume | |
| Avg. volume | 169 |
| Market cap | 5.994M |
| Beta (5Y monthly) | -0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Zacks
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
AnaptysBio (ANAB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
© 2024 Yahoo. All rights reserved.